David Rawlings, MD

My laboratory focuses on studies of altered lymphoid development and signaling leading to immunodeficiency, autoimmunity and/or malignancies, and development of gene therapy and gene editing for immune diseases. We use expertise in basic and clinical immunology, signal transduction and developmental biology to understand how altered signals can lead to immunologic disease, with the goal of developing translational therapies that specifically modulate key pathways. I am interested in mentoring, education, and career development of ITI fellows by serving as a scientific mentor.